Background/Aims: There is increasing evidence that exposure to air pollutants, including particulate matter (PM2.5, PM10), nitrogen dioxide (NO2), and sulfur dioxide (SO2), might aggravate preexisting skin diseases such as eczema and urticaria. Here we investigated if a possible link exists between air pollution and acne vulgaris. We assessed the association between ambient air pollutant concentrations and the number of visits of patients for acne vulgaris to a dermatological outpatient clinic in Beijing, China, from April 1, 2012 to April 30, 2014. Methods: In this time period, 59,325 outpatient visits were recorded because of acne vulgaris. Daily air pollution parameters for PM10, PM2.5, SO2, and NO2 were obtained from the Beijing Municipal Environmental Monitoring Center. Results: Increased concentrations of ambient PM2.5, PM10, and NO2 were significantly associated with increased numbers of outpatient visits for acne vulgaris over the 2 years. These effects could be observed for NO2 in a single-pollutant model and for PM2.5, PM10, and NO2 in 2-pollutant models, which are closer to real-life exposure. Of note, these effects were specific because they were not observed for increased SO2 concentrations, which even showed negative correlations in all test models. Conclusion: This study provides indirect evidence for a link between acne vulgaris and air pollution.

Keywords:
Air pollution, Particulate matter, Acne vulgaris, Time-series study, China
1.
World Health Organization: Review of evidence on health aspects of air pollution - REVIHAAP project: final technical report. 2013. http://www.euro.who.int/en/health-topics/environment-and-health/air-quality/publications/2013/review-of-evidence-on-health-aspects-of-air-pollution-revihaap-project-final-technical-report/ (accessed September 7, 2016).
2.
Vierkötter A, Schikowski T, Ranft U, Sugiri D, Matsui M, Krämer U, Krutmann J: Airborne particle exposure and extrinsic skin aging. J Invest Dermatol 2010;130:2719-2726.
3.
Hüls A, Vierkötter A, Gao W, Krämer U, Yang Y, Ding A, Stolz S, Matsui M, Kan H, Wang S, Jin L, Krutmann J, Schikowski T: Traffic-related air pollution contributes to development of facial lentigines: further epidemiological evidence from Caucasians and Asians. J Invest Dermatol 2016;136:1053-1056.
4.
Krämer U, Sugiri D, Ranft U, Krutmann J, von Berg A, Berdel D, Behrendt H, Kuhlbusch T, Hochadel M, Wichmann HE, Heinrich J: Eczema, respiratory allergies, and traffic-related air pollution in birth cohorts from small-town areas. J Dermatol Sci 2009;56:99-105.
5.
Xu F, Yan S, Wu M, Li F, Xu X, Song W, Zhao J, Xu J, Kan H: Ambient ozone as a risk factor for skin disorders. Br J Dermatol 2011;165:224-225.
6.
Moradi Tuchayi S, Makarantonaki E, Ganceviciene R, Dessinoti C, Feldmann SR, Zouboulis CC: Acne vulgaris. Nat Rev Dis Primers 2015;1:15029.
7.
Lefebvre MA, Pham DM, Boussouira B, Qiu H, Ye C, Long X, Chen R, Gu W, Laurent A, Nguyen QL: Consequences of urban pollution upon skin status: a controlled study in Shanghai area. Int J Cosmet Sci 2016;38:217-223.
8.
Lefebvre MA, Pham DM, Boussouira B, Bernard D, Camus C, Nguyen QL: Evaluation of the impact of urban pollution on the quality of skin: a multicentre study in Mexico. Int J Cosmet Sci 2015;37:329-338.
9.
Larrieu S, Lefranc A, Gault G, Chatignoux E, Couvy F, Jouves B, Filleul L: Are the short-term effects of air pollution restricted to cardiorespiratory diseases. Am J Epidemiol 2009;169:1201-1208.
10.
Morgenstern V, Zutavern A, Cyrys J, Brockow I, Koletzko S, Krämer U, Behrendt H, Herbarth O, von Berg A, Bauer CP, Wichmann HE, Heinrich J: Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children. Am J Respir Crit Care Med 2008;177:1331-1337.
11.
World Health Organization: Ambient air pollution: a global assessment of exposure and burden of disease. 2016, p 27. http://who.int/phe/publications/air-pollution-global-assessment/en/ (accessed September 25, 2017).
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.